Monday, May 27, 2019
Home News Medical Marijuana Dispensary targets life in North Dakota and delivery to Dakota...

Medical Marijuana Dispensary targets life in North Dakota and delivery to Dakota Manufacturing. Other OTC: INLB

GRAND FORKS, North Dakota, February 20, 2019 (GLOBE NEWSWIRE) – # 9 Labs Corp. (OTC: INLB) (# 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms. announced today that the medical marijuana dispensary, Strive Life North Dakota, a partner of the company's business model and brand, has signed a letter of intent with Pure Dakota, LLC, a leading supplier and manufacturer of salable marijuana.

The deal is the first of its kind in the country and will ensure a steady supply of much-anticipated marijuana medicines as soon as Strive Life North Dakota opens its doors.

For more information, visit

The operation of Strive Life in North Dakota follows the business model of Strive Life, which introduces the best medical marijuana practices in the United States and globally. The dispensary model provides thoughtful environments for a higher patient experience.

"We look forward to having Pure Dakota as one of our key suppliers," said Sara Gullickson, CEO of Item 9 Labs.

Strive Life North Dakota was approved in November 2018 for a registration certificate for a pharmacy, one of only eight state-awarded certificates. The surgery is expected to begin in April / May 2019 and will provide a diverse inventory of patient-focused products.

"We have absolute respect for Pure Dakota. Together, as trusted providers, we will promote patient wellbeing, "commented Jonathan O`Keefe, founder of Strive Life North Dakota.

Pure Dakota operates a 20,000-square-meter facility and houses 1,000 marijuana plants, the maximum under state law. It is one of two licensed manufacturers in North Dakota.

In addition to the Strive Life brand, Item 9 Labs is an industry leader in the development and manufacture of innovative marijuana products and proprietary delivery platforms. Item 9 Labs will operate as licensed pharmacies, manufacturing and manufacturing facilities in approved US markets by the end of 2019.

For more information, see

Information about Article 9 Labs Corp.:

Item 9 Labs Corp. (OTC: INLB) creates convenient cannabis health solutions for the modern consumer through the development of innovative products and proprietary delivery platforms. The company is focused on developing technology and products that manage high-quality medical marijuana through a novel intra-nasal delivery system for significant health benefits. The company is headquartered in Southern Arizona, where it owns and operates 50 acres, one of the largest properties in the US where the medical marijuana flower is grown. Point 9 has proven to be successful in providing consumers with high quality medicinal marijuana flowers and products that are targeted at organic, cost-effective body health solutions. By combining a high-quality medical device with the company's proprietary nasal mucosal delivery system, Item 9 plans to launch the industry's first commercial nasal delivery device, which will deliver specific cannabinoid dosages to meet the growing needs of the modern To cover today's cannabis users. For more information visit us online at and,

Forward-looking statement:
This news release contains forward-looking statements within the meaning of the Safe Harbor provisions of the Private Infringement Procedures Act 1995. These statements involve risks and uncertainties, including risks and repercussions of legal and administrative procedures as well as government regulation, particularly in a foreign country, future financial and operating results, competition, general economic conditions, planned transactions that are not legally binding obligations of the Company, and the ability to control and continue the growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those stated. Important factors that could cause actual results to differ materially from the forward-looking statements made in this press release include the introduction of new technology, market conditions and those contained in reports or documents that we occasionally file with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date of this Agreement or the occurrence of unexpected events.

Media Contact:
Neko Catanzaro
Proven media
(401) 484-4980

Contact for investors:
Jeffrey Rassas
Item 9 Labs Corp.
(602) 463-4246



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Must Read

"We must inform consumers of the" social cost "of goods and services offered"

Brian Hill CNRS researcher and affiliated professor at HEC, responsible for decision, logic and philosophy courses To encourage...

Jeep Elite: Nanterre falls in Pau and will play a beautiful

Nanterre could not confirm. Flamboyant Friday at home for the quarter-final first leg, the Parisians had a different match this Sunday in Pau. Abused...

Elia Suleiman receives a special mention from the jury for It Must Be Heaven in Cannes

The Palestinian filmmaker, winner of the 2002 Jury Prize, was awarded a special prize on Saturday night at the closing ceremony of the 72nd...

No cloud required: Why AI's future is at the edge

The algorithms for running AI applications have been so big and complex that they have required processing on powerful machines in the cloud and...

Municipal elections 26m: Maragall wins Colau in votes in Barcelona but tie in councilors | Catalonia

Barcelona has decided this Sunday for just over 4,800 votes to leave behind the four years of Ada Colau as mayor, and gave the...